menu
    • menu

    Find Defibrotide Sodium manufacturers, exporters & distributors on PharmaCompass

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    0

    Listed Suppliers

    Other Suppliers

    0INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    3

    FDF Dossiers

    FDF Dossiers

    1

    FDA Orange Book

    FDA (Orange Book)

    1

    Europe

    Europe

    1

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    1DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    3

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 0

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    1,162

    Regulatory FDF Prices

    NA

    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    8

    API

    3

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    4

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Jazz Pharmaceuticals Stops Enrollment in Phase 3 Study Evaluating Defibrotide for the Prevention of Veno-Occlusive Disease

    Details:

    Enrollment in the study was stopped early based on the recommendation from an IDMC, which concluded it would be highly unlikely to reach statistical significance for the primary endpoint.


    Lead Product(s): Defibrotide Sodium,Inapplicable

    Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 29, 2020

    blank

    01

    Jazz Pharmaceuticals

    Ireland
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Jazz Pharmaceuticals

    Ireland
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Defibrotide Sodium,Inapplicable

    Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Jazz Pharmaceuticals Stops Enrollment in Phase 3 Study Evaluating Defibrotide for the Prevention o...

    Details : Enrollment in the study was stopped early based on the recommendation from an IDMC, which concluded it would be highly unlikely to reach statistical significance for the primary endpoint.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    April 29, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    APIs

    read-more
    read-more
    india-flag.png
    Injectable Grade Defibrotide Sodium API needed in India [ENA22621]
    A company that focuses on research, development and manufacturing of active ingredients and FDFs is looking for suppliers of Injectable Grade Defibrotide Sodium API. The required quantity is 125 g for development, 375 g for exhibit batches and 125 g for commercial purposes. The suppliers must support this enquiry with GMP & CoA.
    11 Apr 2025

    Reply

    11 Apr 2025

    Reply text-arrow

    Reply Comment (1)

    11 Apr 2025

    india-flag.png
    Injectable Grade Defibrotide Sodium (MOQ) API needed in India [ENA18080]
    A biotechnology company that focuses on the research, development and manufacturing of immunosuppressants, antibiotics, oncology, anti-obesity, hypolipemic segments and enzymes is looking for suppliers of Injectable Grade Defibrotide Sodium (MOQ) API for development purposes. The suppliers must support this enquiry with CoA.
    18 Sep 2023

    Reply

    18 Sep 2023

    Reply text-arrow

    Reply Comment (1)

    18 Sep 2023

    india-flag.png
    Various APIs needed in India [ENA17258]
    A company that deals in various pharmaceutical products is looking for suppliers of Various APIs for commercial purposes. The required quantity is MOQ for each. The suppliers must support this enquiry with CoA. 1. Bemiparin Sodium API 2. Defibrotide Sodium API 3. Ataluren API 4. Vandetanib API 5. Chenodeoxycholic Acid API
    08 Jun 2023

    Reply

    08 Jun 2023

    Reply text-arrow

    Reply Comment (3)

    08 Jun 2023

    turkeypng-1602828403png-1622460951png-1622462103.png
    Defibrotide Sodium API needed in Turkey [ENA17150]
    A company that focuses on research, development and manufacturing of finished formulations in respiratory, oncology & hematology therapeutic areas is looking for suppliers of Defibrotide Sodium API. The required quantity is 200 g for development and 2 kg for commercial purposes. The suppliers must support this enquiry with GMP & CoA.
    23 May 2023

    Reply

    23 May 2023

    Reply text-arrow

    Reply Comment (5)

    23 May 2023

    Jordan.png
    Various APIs needed in Jordan [ENA12801]
    A company that deals in the development, production, and distribution of generic and specialty medicines is looking for suppliers of Various APIs. The suppliers must support this enquiry with CoA. 1. Fondaparinux Sodium API 2. Defibrotide API 3. Bulevirtide API 4. Iron Isomaltoside API 5. Dalteparin Sodium API
    24 Feb 2022

    Reply

    24 Feb 2022

    Reply text-arrow

    Reply Comment (12)

    24 Feb 2022

    turkeypng-1602828403png-1622460951png-1622462103.png
    Various APIs needed in Turkey [ENA08324]
    An innovative and growth-oriented pharmaceutical Turkish company is looking for suppliers of Various APIs. The suppliers must support this enquiry with DMF or CEP & GMP. 1. Carfilzomib API. The required quantity is 3 g for research purposes & 750 g - 1 kg/ annum for commercial purposes 2. Defibrotide API. The required quantity is 7 kg for research purposes & 25 kg/ annum for commercial purposes 3. Etelcalcetide HCl API. The required quantity is 4 g for research purposes & 100 g/ annum for commercial purposes 4. Nelarabine API. The required quantity is 510 g/annum 5. Ribociclib Succinate API. The quantity is not clear yet. 6. Sodium Benzoate API. The required quantity is 50 kg - 60 kg/ annum 7. Vandetanib API. The required quantity is 10 g - 15 g for research purposes & 7.5 kg/ annum for commercial purposes 8. Vorinostat API. The required quantity is 10 g for research purposes & 12 kg/ annum for commercial purposes
    21 Aug 2020

    Reply

    21 Aug 2020

    Reply text-arrow

    Reply Comment (13)

    21 Aug 2020

    turkeypng-1602828403png-1622460951png-1622462103.png
    Various APIs needed in Turkey [ENA06471]
    A pharmaceutical manufacturing company that focuses on the fields of oncology, hematology, ophthalmology, and radiology is looking for suppliers of Various APIs for R&D purposes. The suppliers must support this enquiry GMP & USDMF. 1. Nelarabine 2. Defibrotide 3. Eribulin
    04 Feb 2020

    Reply

    04 Feb 2020

    Reply text-arrow

    Reply Comment (13)

    04 Feb 2020

    Market Place
    Enquiry// Carvedilol Phosphate, Nusinersen and other APIs needed in India [ENA01667]
    Esschem Pvt Ltd- a rapidly growing pharmaceutical company based in India is looking for the suppliers of the following: 1) Carvedilol Phosphate 2) Nusinersen 3) Eteplirsen 4) Edaravone 5) Etelcalcetide 6) Abaloparatide 7) Defibrotide 8) Rolapitant Interested suppliers must contact Subramaniam via E-mail: subu@esschemindia.com or Tel: +919819619256.
    28 Aug 2018

    Reply

    28 Aug 2018

    Reply text-arrow

    Reply Comment (1)

    28 Aug 2018

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search